Squamous Cell Carcinoma of Head and Neck: all 1,711 studies

Page 16 of 18. Open to participants first (544), then studies with results posted, then the rest; newest registration first within each.

• State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning StudyCompletedNCT02242916
• Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and NeckTerminatedNCT02236936Phase 3
• Phase II Trial of HM781-36B in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of or Unfit for Platinum-containing TherapyStatus unknownNCT02216916Phase 2
• Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNAWithdrawnNCT02211027Phase 1
• Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab TherapyTerminatedNCT02205398Phase 1
• Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and NeckTerminatedNCT02201355Phase 1
• Window Trial 5-aza in HNSCC, T-tareCompletedNCT02178072Phase 1
• Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and NeckCompletedNCT02158234Phase 1
• Identification of Breath Biomarkers in Head and Neck Squamous Cell CarcinomaSuspendedNCT02156180
• Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaCompletedNCT02147418
• An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.Status unknownNCT02145312Phase 2
• Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma PatientsWithdrawnNCT02143622Phase 1/2
• The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer StudyStatus unknownNCT02126189
• A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus NivolumabTerminatedNCT02124850Phase 1
• Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral CavityWithdrawnNCT02119728Phase 2
• Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell CarcinomaStatus unknownNCT02119559Not applicable
• Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02110992Phase 1
• Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckCompletedNCT02061631Phase 2
• SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHNCompletedNCT02057107Phase 2
• A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and NeckStatus unknownNCT02054442Phase 1/2
• Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerCompletedNCT02048020Phase 2
• Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCCCompletedNCT02047201Phase 2
• Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)TerminatedNCT02045186Not applicable
• Interest of Narrow Band Imaging in Detection of Upper Aerodigestive CancersCompletedNCT02035735Not applicable
• Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02035527Phase 1
• Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer PatientsCompletedNCT02025062Not applicable
• Protocole Advanced RadioTherapy ORLCompletedNCT02024035
• Debio 1143-201 Dose-finding and Efficacy Phase I/II TrialCompletedNCT02022098Not applicable
• Does the Harmonic Scalpel Reduce Blood Loss and OR Time in Major Head and Neck Cancer Surgery Undergoing Major Surgery for Oral Cavity Squamous Cell Carcinoma?CompletedNCT02017834Not applicable
• Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and NeckTerminatedNCT02015650Phase 4
• The Role of microRNA-29b in the Oral Squamous Cell CarcinomaStatus unknownNCT02009852
• Trismus Prevention, Diagnosis and Management: Radiotherapy Planning, Early Detection, and Physical Therapy InterventionStatus unknownNCT02004639Not applicable
• Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck CancerCompletedNCT02003482
• Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and NeckCompletedNCT01998542Phase 2
• Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell CarcinomaStatus unknownNCT01987934
• A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced MucositisTerminatedNCT01975688Phase 1
• Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor TherapyWithdrawnNCT01967927Early Phase 1
• NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)CompletedNCT01950689Phase 3
• The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell CarcinomaStatus unknownNCT01946230
• Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer PatientsCompletedNCT01941992Phase 2
• Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck CancerCompletedNCT01935921Phase 1
• Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.Status unknownNCT01927354
• A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)CompletedNCT01911598Phase 1
• Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal CancerActive, not recruitingNCT01893307Phase 3
• Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNNCompletedNCT01884259Phase 2
• A Prospective Study of Prophylactic Gastrostomy in Head and Neck Cancer Patients Undergoing ChemoradiotherapyTerminatedNCT01876693Not applicable
• Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCCStatus unknownNCT01874171Phase 3
• Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCCCompletedNCT01864850Phase 3
• Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell CarcinomaStatus unknownNCT01855451Phase 3
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerCompletedNCT01847326Phase 1
• Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast CancerCompletedNCT01846091Phase 1
• Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT01830556Phase 2
• Pathological Validation of Functional Imaging in Head and Neck Squamous Cell CarcinomaTerminatedNCT01827709Not applicable
• A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)WithdrawnNCT01820312Phase 2
• Efficacy and Safety of TORS for SCCAActive, not recruitingNCT01819480Not applicable
• Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental CareCompletedNCT01816841Not applicable
• Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerSuspendedNCT01810913Phase 2/3
• Oral Rigosertib for Squamous Cell CarcinomaCompletedNCT01807546Phase 2
• Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive TherapyCompletedNCT01794481Not applicable
• Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck CancerCompletedNCT01783587Phase 1
• Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal CarcinomaCompletedNCT01783158
• Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and NeckCompletedNCT01737008Phase 1
• Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyWithdrawnNCT01728480Phase 1
• Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerCompletedNCT01727076Phase 1
• A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent ChemoradiotherapyTerminatedNCT01720563Phase 2
• Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT01716416Phase 1
• Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01695122Phase 2
• Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck CancerCompletedNCT01689194Phase 2
• Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation TherapyWithdrawnNCT01674374Phase 2
• The Head and Neck Tumor BiobankCompletedNCT01644786
• Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerCompletedNCT01637194Phase 1
• A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.TerminatedNCT01606566Phase 2
• A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric CancerCompletedNCT01598077Phase 1
• Developing an In-vitro Diagnostic Risk-Stratification Test for Oral CancerStatus unknownNCT01587573
• Stereotactic Boost for Oropharyngeal Squamous Cell CarcinomaWithdrawnNCT01586182Phase 1/2
• A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And NeckCompletedNCT01577173Phase 2
• TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell CarcinomaCompletedNCT01542931Phase 2/3
• Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and NeckCompletedNCT01538381Phase 2
• Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01528163Phase 2
• Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerTerminatedNCT01528137Phase 1
• Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and NeckStatus unknownNCT01527877Phase 2
• Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01515137Phase 1
• IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01507467Phase 3
• Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT01491139Phase 1
• A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01484847Not applicable
• Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.CompletedNCT01469429Phase 1/2
• PF-00299804 in Patients With Head and Neck Squamous Cell CarcinomaCompletedNCT01449201Phase 2
• Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and NeckCompletedNCT01427478Phase 3
• Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)WithdrawnNCT01427205Phase 2
• Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell CarcinomaCompletedNCT01425736Phase 2
• Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC PatientsCompletedNCT01415674Phase 2
• Cabazitaxel - PF Induction ChemotherapyCompletedNCT01379339Phase 1
• Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT01377298Phase 2
• EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01360827Phase 1
• Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to TherapyCompletedNCT01358097
• Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.CompletedNCT01353625Phase 1
• Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.CompletedNCT01341535Phase 2
• Survival Benefit of Elective Neck Dissection in T1,2N0M0 Oral Squamous Cell CarcinomaStatus unknownNCT01334320Not applicable
• TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckCompletedNCT01334177Phase 1
• Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and NeckStatus unknownNCT01333696Phase 2

← Squamous Cell Carcinoma of Head and Neck overview